annual EBITDA:
-$215.24M-$9.56M(-4.65%)Summary
- As of today (September 10, 2025), DAWN annual EBITDA is -$215.24 million, with the most recent change of -$9.56 million (-4.65%) on December 31, 2024.
- During the last 3 years, DAWN annual EBITDA has fallen by -$142.70 million (-196.70%).
- DAWN annual EBITDA is now -1479.52% below its all-time high of -$13.63 million, reached on December 31, 2020.
Performance
DAWN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$34.01M+$6.16M(+15.34%)Summary
- As of today (September 10, 2025), DAWN quarterly EBITDA is -$34.01 million, with the most recent change of +$6.16 million (+15.34%) on June 30, 2025.
- Over the past year, DAWN quarterly EBITDA has increased by +$80.39 million (+70.27%).
- DAWN quarterly EBITDA is now -139.15% below its all-time high of $86.88 million, reached on March 1, 2019.
Performance
DAWN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$108.37M+$80.39M(+42.59%)Summary
- As of today (September 10, 2025), DAWN TTM EBITDA is -$108.37 million, with the most recent change of +$80.39 million (+42.59%) on June 30, 2025.
- Over the past year, DAWN TTM EBITDA has increased by +$183.43 million (+62.86%).
- DAWN TTM EBITDA is now -160.31% below its all-time high of $179.70 million, reached on September 1, 2019.
Performance
DAWN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DAWN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.7% | +70.3% | +62.9% |
| 3 y3 years | -196.7% | +7.0% | -2.9% |
| 5 y5 years | -1343.9% | -1345.4% | -225.9% |
DAWN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -196.7% | at low | -211.9% | +70.3% | -2.9% | +62.9% |
| 5 y | 5-year | -1479.5% | at low | -211.9% | +70.3% | -225.9% | +62.9% |
| alltime | all time | -1479.5% | at low | -139.2% | +70.3% | -160.3% | +62.9% |
DAWN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$34.01M(-15.3%) | -$108.37M(-42.6%) |
| Mar 2025 | - | -$40.17M(-37.8%) | -$188.76M(-12.3%) |
| Dec 2024 | -$215.24M(+4.6%) | -$64.57M(-312.5%) | -$215.24M(+2.5%) |
| Sep 2024 | - | $30.38M(-126.6%) | -$210.08M(-28.0%) |
| Jun 2024 | - | -$114.40M(+71.6%) | -$291.80M(+28.8%) |
| Mar 2024 | - | -$66.65M(+12.2%) | -$226.57M(+10.2%) |
| Dec 2023 | -$205.68M(+40.5%) | -$59.41M(+15.7%) | -$205.68M(+8.9%) |
| Sep 2023 | - | -$51.34M(+4.4%) | -$188.83M(+6.7%) |
| Jun 2023 | - | -$49.16M(+7.4%) | -$177.03M(+7.6%) |
| Mar 2023 | - | -$45.77M(+7.5%) | -$164.45M(+12.3%) |
| Dec 2022 | -$146.38M(+101.8%) | -$42.56M(+7.7%) | -$146.38M(+16.4%) |
| Sep 2022 | - | -$39.53M(+8.1%) | -$125.71M(+19.3%) |
| Jun 2022 | - | -$36.59M(+32.1%) | -$105.36M(+25.2%) |
| Mar 2022 | - | -$27.70M(+26.5%) | -$84.16M(+16.1%) |
| Dec 2021 | -$72.54M | -$21.89M(+14.1%) | -$72.51M(+29.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$19.18M(+24.7%) | -$56.12M(+37.8%) |
| Jun 2021 | - | -$15.39M(-4.0%) | -$40.73M(+47.1%) |
| Mar 2021 | - | -$16.04M(+190.9%) | -$27.69M(+103.2%) |
| Dec 2020 | -$13.63M(-8.6%) | -$5.51M(+45.6%) | -$13.63M(-185.2%) |
| Sep 2020 | - | -$3.79M(+60.9%) | $16.00M(-81.4%) |
| Jun 2020 | - | -$2.35M(+19.1%) | $86.09M(-5.1%) |
| Mar 2020 | - | -$1.98M(-108.2%) | $90.75M(-49.5%) |
| Dec 2019 | -$14.91M | - | - |
| Dec 2019 | - | $24.11M(-63.6%) | $179.60M(-0.1%) |
| Sep 2019 | - | $66.31M(+2780.5%) | $179.70M(+10.2%) |
| Jun 2019 | - | $2.30M(-97.4%) | $163.08M(-6.0%) |
| Mar 2019 | - | $86.88M(+258.8%) | $173.47M(+100.3%) |
| Dec 2018 | - | $24.22M(-51.3%) | $86.60M(+38.8%) |
| Sep 2018 | - | $49.69M(+291.3%) | $62.38M(+391.3%) |
| Jun 2018 | - | $12.70M | $12.70M |
FAQ
- What is Day One Biopharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Day One Biopharmaceuticals, Inc.?
- What is Day One Biopharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Day One Biopharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Day One Biopharmaceuticals, Inc.?
- What is Day One Biopharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Day One Biopharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Day One Biopharmaceuticals, Inc.?
- What is Day One Biopharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Day One Biopharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of DAWN is -$215.24M
What is the all time high annual EBITDA for Day One Biopharmaceuticals, Inc.?
Day One Biopharmaceuticals, Inc. all-time high annual EBITDA is -$13.63M
What is Day One Biopharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, DAWN annual EBITDA has changed by -$9.56M (-4.65%)
What is Day One Biopharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of DAWN is -$34.01M
What is the all time high quarterly EBITDA for Day One Biopharmaceuticals, Inc.?
Day One Biopharmaceuticals, Inc. all-time high quarterly EBITDA is $86.88M
What is Day One Biopharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, DAWN quarterly EBITDA has changed by +$80.39M (+70.27%)
What is Day One Biopharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of DAWN is -$108.37M
What is the all time high TTM EBITDA for Day One Biopharmaceuticals, Inc.?
Day One Biopharmaceuticals, Inc. all-time high TTM EBITDA is $179.70M
What is Day One Biopharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, DAWN TTM EBITDA has changed by +$183.43M (+62.86%)